| 中文名稱:Metolazone | 英文名稱:Metolazone |
| CAS:17560-51-9 | 品牌: 一研 |
| 保存條件: Store at -20°C | 產(chǎn)品類別: 抑制劑 |
| Cas : 17560-51-9 |
產(chǎn)品屬性:
產(chǎn)品名稱 | 規(guī)格 | CAS號 | 型號 |
Metolazone | 50mg | 17560-51-9 | EY-Y0164247 |
Cas No.17560-51-9
別名
化學(xué)名 7-chloro-2-methyl-4-oxo-3-(o-tolyl)-1,2,3,4-tetrahydroquinazoline-6-sulfonamide
分子式 C16H16ClN3O3S

分子量 365.83
溶解度 ≥ 108.2mg/mL in DMSO
儲存條件 Store at -20°C
General tips For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.
Shipping Condition Evaluation sample solution : ship with blue ice
All other available size: ship with RT , or blue ice upon request
產(chǎn)品描述:
Metolazone(Zaroxolyn) is primarily used to treat congestive heart failure and high blood pressure.Target: OthersMetolazone is a thiazide-like diuretic marketed under the brand names Zytanix from Zydus Cadila, Zaroxolyn, and Mykrox. It is primarily used to treat congestive heart failure and high blood pressure. Metolazone indirectly decreases the amount of water reabsorbed into the bloodstream by the kidney, so that blood volume decreases and urine volume increases. This lowers blood pressure and prevents excess fluid accumulation in heart failure. Metolazone is sometimes used together with loop diuretics such as furosemide or bumetanide, but these highly effective combinations can lead to dehydration and electrolyte abnormalities.Metolazone and the other thiazide diuretics inhibit the function of the sodium-chloride symporter, preventing sodium and chloride, and therefore water too, from leaving the lumen to enter the tubule cell. As a result, water remains in the lumen and is excreted as urine, instead of being reabsorbed into the bloodstream. Since most of the sodium in the lumen has already been reabsorbed by the time the filtrate reaches the distal convoluted tubule, thiazide diuretics have limited effects on water balance and on electrolyte levels. Nevertheless, they can be associated with low sodium levels, volume depletion, and low blood pressure, among other adverse effects.
References:
[1]. Stern A. Metolazone, a diuretic agent. Am Heart J. 1976 Feb;91(2):262-3.
[2]. Thompson DM. A new antihypertensive: metolazone treatment of hypertension. J Kans Med Soc. 1977 Jul;78(7):337-9, 342.
| 成立日期 | 2014-06-05 (13年) | 注冊資本 | 100 |
| 員工人數(shù) | 50-100人 | 年營業(yè)額 | ¥ 100萬以內(nèi) |
| 主營行業(yè) | 生化試劑,抗體,細(xì)胞培養(yǎng),分子生物學(xué),免疫安全 | 經(jīng)營模式 | 工廠,試劑 |
| 產(chǎn)品名稱 | 價格 | 公司名稱 | 報價日期 | |
|---|---|---|---|---|
| 詢價 |
VIP2年
|
湖北揚信醫(yī)藥科技有限公司
|
2026-07-22 | |
| ¥239.90 |
VIP14年
|
上海阿拉丁生化科技股份有限公司
|
2026-06-23 | |
| ¥239.90 |
VIP3年
|
上海阿拉丁生化科技股份有限公司
|
2026-06-10 | |
| 詢價 |
南京百鑫德諾生物科技有限公司
|
2024-09-26 | ||
| 詢價 |
廣州貝爾卡生物科技有限公司
|
2024-03-04 | ||
| ¥115 |
湖北麥凱斯精化科技有限公司
|
2023-03-23 | ||
| 詢價 |
武漢鵬胤藥業(yè)有限公司
|
2020-09-12 |